Test Price
800 AED✅ Home Collection Available
Chromosome Analysis for Hematologic Malignancy (Cytogenetic Karyotyping) – 800 AED | 4-Day TAT | DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity through ISO 9001:2015 certified processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital extraction only – sample collection conducted strictly within an accredited hospital facility; mobile home phlebotomy disabled for safety.
- Clinical Guidance: Dedicated telephonic post-test consultation with a Consultant Medical Genetics to interpret chromosomal findings and coordinate with your treating hematologist.
- Insurance: Direct verification and approval activation via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This comprehensive cytogenetic analysis cultures bone marrow or peripheral blood cells obtained under strict hospital conditions, then performs Giemsa‑banded karyotyping using robotic microscopy to detect numerical and structural chromosomal abnormalities associated with hematologic malignancies. The test provides whole‑genome screening at 400–550 band resolution, identifying both known and novel clonal abnormalities critical for leukemia subtyping and treatment planning.
| Feature | Our Test – Chromosome Analysis (Karyotyping) | Closest Alternative – FISH Panel |
|---|---|---|
| Precision | Whole‑genome screening at 400–550 band resolution; detects both known and novel abnormalities | Targeted evaluation of specific gene loci (e.g., BCR-ABL1, PML-RARA); cannot uncover chromosomal abnormalities beyond probes |
| Methodology | Short‑term culture + G‑banding, automated/robotic microscopy & conventional karyotyping | Fluorescence in situ hybridization (FISH) on interphase nuclei |
| Turnaround Time | 4 working days | 2–3 working days |
Physician Insight & Safety Protocols
🩺 Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
“I understand the uncertainty that comes with a possible hematologic malignancy, and this chromosome analysis provides a critical genetic roadmap for your care. The findings must always be correlated with your clinical history, blood counts, and other molecular studies — they are not a standalone verdict. I strongly recommend discussing every result with your treating hematologist‑oncologist, who can integrate this information into a comprehensive, personalized treatment plan.”
Advisory Message
⚠️ Medication Warning
Do not discontinue prescribed medication, especially anticoagulants or chemotherapy, without direct consultation with your physician.
Exclusion Criteria & Emergency Red Flags
- • Active systemic infection or uncorrected coagulopathy (INR >1.5, platelets <20,000/µL without transfusion support).
- • Patient unable to lie still or provide informed consent.
- • Incomplete or missing Chromosome & FISH Analysis Requisition Form (Form 17).
- • ER Red Flags post‑procedure: Severe bleeding at puncture site, syncope, fever >38.5°C, or intense pain unresponsive to simple analgesia — seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What does chromosome analysis for hematologic malignancy detect?
Karyotyping detects clonal chromosomal abnormalities, such as translocations or deletions, in blood or marrow cells, guiding precise leukemia subtype classification and treatment decisions.
2. How should I prepare for the bone marrow or blood sample collection?
No fasting is required; however, you must complete the mandatory Chromosome & FISH Analysis Requisition Form (Form 17) and inform staff about blood thinners or bleeding disorders.
3. When will I receive my results, and how are they interpreted?
Your report is dispatched within 4 working days; a dedicated clinical coordinator provides a telephonic post‑consultation to explain chromosomal findings and coordinate with your oncologist for integrated care.
UAE Regulatory & Data Privacy Adherence
- Licensed by Dubai Health Authority (DHA) – Facility License 1143
- Strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Compliant with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- All processes certified under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Clinical & Logistical Metadata
| Test Name | Chromosome Analysis for Hematologic Malignancy (Cytogenetic Karyotyping) |
| Price (AED) | 800 |
| Turnaround Time | 4 working days |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Short‑term culture + G‑banding, automated/robotic microscopy & conventional karyotyping |
| ICD-10-CM Code | C91.90 (Lymphoid leukemia, unspecified without remission), D46.9 (Myelodysplastic syndrome, unspecified) |
| LOINC Code | 33717-0 (Cytogenetics study result in Blood or Marrow) |
| DHA Facility License & Laboratory Address Invariants | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE - License #1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians